In such an event, the line of treatment should be by addressing the signs and symptoms first
Efficacy and safety of once-weekly glucagon-like peptide 1 receptor agonist albiglutide (HARMONY 1 trial): 52-week primary endpoint results from a randomized, double-blind, placebo-controlled trial in patients with type 2 diabetes mellitus not controlled on pioglitazone, with or without metformin
their use of GLP-1 [drugs] are much, much higher than people covered by insurance with less generous coverage or no insurance," said Hui Shao, associate professor of global health and author on the study
If you feel at immediate risk or unable to keep yourself safe, call 999 or go to your nearest A&E department
Sharing her views on her Instagram handle, she penned: "Taking care of yourself isn't a weakness, it's a power